Common use of DRUG DETECTION AND DETERRENCE Clause in Contracts

DRUG DETECTION AND DETERRENCE. 12.3.1 It is the policy of the City to achieve a drug-free workforce and workplace. The manufacture, distribution, dispensation, possession, sale, or use of illegal drugs or alcohol by contractors while on City Premises is prohibited. Concessionaire shall comply with all the requirements and procedures set forth in the Mayor's Drug Abuse Detection and Deterrence Procedures for Contractors, Executive Order No. 1-31 ("Executive Order"), which is incorporated into this Agreement and is on file in the City Secretary’s Office. 12.3.2 Before the City signs this Agreement, Concessionaire shall file with the Contract Compliance Officer for Drug Testing ("CCODT"): (a) a copy of its drug-free workplace policy, (b) the Drug Policy Compliance Agreement substantially in the form set forth in Exhibit “F”, together with a written designation of all safety impact positions and, (c) if applicable (e.g., no safety impact positions), the Certification of No Safety Impact Positions, substantially in the form set forth in Exhibit “G”. If Concessionaire files a written designation of safety impact positions with its Drug Policy Compliance Agreement, it also shall file every 6 months during the performance of this Agreement, a Drug Policy Compliance Declaration in a form substantially similar to Exhibit “H”. Concessionaire shall submit the Drug Policy Compliance Declaration to the CCODT within 30 days of the expiration of each 6-month period of performance and within 30 days of completion of this Agreement. The first 6-month period begins to run on the date the City issues its Notice to Proceed or if no Notice to Proceed is issued, on the first day Concessionaire begins work under this Agreement.

DRUG DETECTION AND DETERRENCE. 12.3.1 11.3.1. It is the policy of the City to achieve a drug-free workforce and workplace. The manufacture, distribution, dispensation, possession, sale, or use of illegal drugs or alcohol by contractors while on City Premises is prohibited. Concessionaire shall comply with all the requirements and procedures set forth in the Mayor's Drug Abuse Detection and Deterrence Procedures for Contractors, Executive Order No. 1-31 ("Executive Order"), which is incorporated into this Agreement and is on file in the City Secretary’s Office. 12.3.2 11.3.2. Before the City signs this Agreement, Concessionaire shall file with the Contract Compliance Officer for Drug Testing ("CCODT"): (a) 11.3.2.1. a copy of its drug-free workplace policy, (b) 11.3.2.2. the Drug Policy Compliance Agreement substantially in the form set forth in Exhibit “F”, together with a written designation of all safety impact positions and, (c) 11.3.2.3. if applicable (e.g., no safety impact positions), the Certification of No Safety Impact Positions, substantially in the form set forth in Exhibit “G”G. 11.3.3. If Concessionaire files a written designation of safety impact positions with its Drug Policy Compliance Agreement, it also shall file every 6 months during the performance of this Agreement, a Drug Policy Compliance Declaration in a form substantially similar to Exhibit “H”. H. Concessionaire shall submit the Drug Policy Compliance Declaration to the CCODT within 30 days of the expiration of each 6-month period of performance and within 30 days of completion of this Agreement. The first 6-month period begins to run on the date the City issues its Notice to Proceed or if no Notice to Proceed is issued, on the first day Concessionaire begins work under this Agreement. Concessionaire also shall file updated designations of safety impact positions with the CCODT if additional safety impact positions are added to Concessionaire's employee work force. Concessionaire shall require that its Subcontractors comply with the Executive Order, and Concessionaire shall secure and maintain the required documents for City inspection.

DRUG DETECTION AND DETERRENCE. 12.3.1 11.3.1. It is the policy of the City to achieve a drug-free workforce and workplace. The manufacture, distribution, dispensation, possession, sale, or use of illegal drugs or alcohol by contractors while on City Premises is prohibitedor 11.3.2. Concessionaire shall comply with all the requirements and procedures set forth in the Mayor's Drug Abuse Detection and Deterrence Procedures for Contractors, Executive Order No. 1-31 ("Executive Order"), which is incorporated into this Agreement and is on file in the City Secretary’s Office. 12.3.2 Before the City signs this Agreement, Concessionaire shall file with the Contract Compliance Officer for Drug Testing ("CCODT"): (a) 11.3.2.1. a copy of its drug-free workplace policy, (b) 11.3.2.2. the Drug Policy Compliance Agreement substantially in the form set forth in Exhibit “F”, together with a written designation of all safety impact positions and, (c) 11.3.2.3. if applicable (e.g., no safety impact positions), the Certification of No Safety Impact Positions, substantially in the form set forth in Exhibit “G”G. 11.3.3. If Concessionaire files a written designation of safety impact positions with its Drug Policy Compliance Agreement, it also shall file every 6 months during the performance of this Agreement, a Drug Policy Compliance Declaration in a form substantially similar to Exhibit “H”. H. Concessionaire shall submit the Drug Policy Compliance Declaration to the CCODT within 30 days of the expiration of each 6-6- month period of performance and within 30 days of completion of this Agreement. The first 6-month period begins to run on the date the City issues its Notice to Proceed or if no Notice to Proceed is issued, on the first day Concessionaire begins work under this Agreement. 11.3.3.1 Concessionaire also shall file updated designations of safety impact positions with the CCODT if additional safety impact positions are added to Concessionaire's employee work force. 11.3.3.2 Concessionaire shall require that its Subcontractors comply with the Executive Order, and Concessionaire shall secure and maintain the required documents for City inspection.

DRUG DETECTION AND DETERRENCE. 12.3.1 11.3.1. It is the policy of the City to achieve a drug-free workforce and workplace. The manufacture, distribution, dispensation, possession, sale, or use of illegal drugs or alcohol by contractors while on City Premises is prohibited. Concessionaire shall comply with all the requirements and procedures set forth in the Mayor's Drug Abuse Detection and Deterrence Procedures for Contractors, Executive Order No. 1-31 ("Executive Order"), which is incorporated into this Agreement and is on file in the City Secretary’s Office. 12.3.2 11.3.2. Before the City signs this Agreement, Concessionaire shall file with the Contract Compliance Officer for Drug Testing ("CCODT"): (a) 11.3.2.1. a copy of its drug-free workplace policy, (b) 11.3.2.2. the Drug Policy Compliance Agreement substantially in the form set forth in Exhibit “F”, together with a written designation of all safety impact positions and, (c) 11.3.2.3. if applicable (e.g., no safety impact positions), the Certification of No Safety Impact Positions, substantially in the form set forth in Exhibit “G”G. 11.3.3. If Concessionaire files a written designation of safety impact positions with its Drug Policy Compliance Agreement, it also shall file every 6 months during the performance of this Agreement, a Drug Policy Compliance Declaration in a form substantially similar to Exhibit “H”. H. Concessionaire shall submit the Drug Policy Compliance Declaration to the CCODT within 30 days of the expiration of each 6-6- month period of performance and within 30 days of completion of this Agreement. The first 6-month period begins to run on the date the City issues its Notice to Proceed or if no Notice to Proceed is issued, on the first day Concessionaire begins work under this Agreement. 11.3.3.1 Concessionaire also shall file updated designations of safety impact positions with the CCODT if additional safety impact positions are added to Concessionaire's employee work force. 11.3.3.2 Concessionaire shall require that its Subcontractors comply with the Executive Order, and Concessionaire shall secure and maintain the required documents for City inspection.

DRUG DETECTION AND DETERRENCE. 12.3.1 10.5.1 It is the policy of the City to achieve a drug-free workforce and workplaceto provide a workplace that is free from the use of illegal drugs and alcohol. The manufacture, distribution, dispensation, possession, sale, sale or use of illegal drugs or alcohol by contractors while on City Premises premises is prohibited. Concessionaire By executing this Agreement, Bus Operator represents and certifies that it meets and shall comply with all the requirements and procedures set forth in the Mayor's Policy on Drug Abuse Detection and Deterrence, City Council Motion No. 92- 1971 (“Mayor's Policy”) and the Mayor's Drug Detection and Deterrence Procedures for Contractors, Executive Order No. 1-31 ("“Executive Order"”), both of which is incorporated into this Agreement and is are on file in the City Secretary’s Office. For purposes of this Section, Bus Operator shall be referred to as “Contractor” in the Exhibits “L”, “M”, and “N”. 12.3.2 Before 10.5.2 Confirming its compliance with the City signs Mayor's Policy and the Executive Order, Bus Operator, as a condition precedent to City's obligations under this Agreement, Concessionaire shall file will have filed with the Contract Compliance Officer for Drug Testing ("“CCODT"):”), prior to the execution of this Agreement by the City: (a) 10.5.2.1 a copy of its drug-free workplace policy, (b) 10.5.2.2 the Drug Policy Compliance Agreement substantially in the form format set forth in Exhibit “FL”, together with a written designation of all safety impact positions and, (c) 10.5.2.3 if applicable (e.g., e.g. no safety impact positions), the Certification of No Safety Impact Positions, substantially in the form set forth in Exhibit “GM”. . 10.5.3 If Concessionaire Bus Operator files a written designation of safety impact positions with its Drug Policy Compliance Agreement, it also shall file every 6 six (6) months during the performance of this AgreementAgreement or upon the completion of this Agreement if performance is less than six (6) months, a Drug Policy Compliance Declaration in a form substantially similar to Exhibit “HN”. Concessionaire Bus Operator shall submit the Drug Policy Compliance Declaration to the CCODT within 30 thirty (30) days of the expiration of each six (6-) month period of performance and within 30 thirty (30) days of completion of this Agreement. The first six (6-) month period begins to run on the date Start Date. 10.5.4 Bus Operator shall have the continuing obligation to file with the CCODT written designations of safety impact positions and Drug Policy Compliance Declarations at any time during the performance of this Agreement that safety impact positions are added if initially no safety impact positions are designated. Bus Operator shall also have the continuing obligation to file updated designations of safety impact positions with the CCODT when additional safety impact positions are added to Bus Operator's work force. 10.5.5 Bus Operator shall require that its subcontractors hereunder to comply with the Mayor's Policy and Executive Order. Bus Operator shall be responsible for securing and maintaining the required documents for City issues its Notice to Proceed or if no Notice to Proceed is issued, on inspection throughout the first day Concessionaire begins work under Term of this Agreement. 10.5.6 Bus Operator’s failure to comply with the above Sections shall be a breach of this Agreement entitling City to terminate in accordance with Article 12.

DRUG DETECTION AND DETERRENCE. 12.3.1 6.5.1 It is the policy of the City to achieve a drug-free workforce and workplace. The manufacture, distribution, dispensation, possession, sale, or use of illegal drugs or alcohol by contractors while on City Premises premises is prohibited. Concessionaire shall comply with all the requirements and procedures set forth in the Mayor's Drug Abuse Detection and Deterrence Procedures for Contractors, Executive Order No. 1-31 ("Executive Order"), which is incorporated into this Agreement and is on file in the City Secretary’s 's Office. Concessionaire is referred to as “Contractor” in Exhibits “E”, “F”, and “G”. 12.3.2 6.5.2 Before the City signs this Agreement, Concessionaire shall file with the Contract Compliance Officer for Drug Testing ("CCODT"): (a) 6.5.2.1 a copy of its drug-free workplace policy,; (b) 6.5.2.2 the Drug Policy Compliance Agreement substantially in the form set forth in Exhibit “F”, "E," together with a written designation of all safety impact positions and, (c) 6.5.2.3 if applicable (e.g., e.g. no safety impact positions), the Certification of No Safety Impact Positions, substantially in the form set forth in Exhibit “G”. "F." 6.5.3 If Concessionaire files a written designation of safety impact positions with its Drug Policy Compliance Agreement, it also shall file every 6 six months during the performance of this AgreementAgreement or on completion of this Agreement if performance is less than 6 months, a Drug Policy Compliance Declaration in a form substantially similar to Exhibit “H”. "G” Concessionaire shall submit the Drug Policy Compliance Declaration to the CCODT within 30 days of the expiration of each 6six-month period of performance and within 30 days of completion of this Agreement. The first 6-six- month period begins to run on the date the City issues its Notice to Proceed or if no Notice to Proceed is issued, on the first day Concessionaire begins work under this Agreement. 6.5.4 Concessionaire also shall file updated designations of safety impact positions with the CCODT if additional safety impact positions are added to Concessionaire's employee work force. 6.5.5 Concessionaire shall require that its subcontractors comply with the Executive Order, and Concessionaire shall secure and maintain the required documents for City inspection.

DRUG DETECTION AND DETERRENCE. 12.3.1 10.3.1 It is the policy of the City to achieve a drug-free workforce and workplace. The manufacture, distribution, dispensation, possession, sale, or use of illegal drugs or alcohol by contractors while on City Premises is prohibited. Concessionaire shall comply with all the requirements and procedures set forth in the Mayor's Drug Abuse Detection and Deterrence Procedures for Contractors, Executive Order No. 1-31 ("Executive Order"), which is incorporated into this Agreement and is on file in the City Secretary’s 's Office. 12.3.2 10.3.2 Before the City signs this Agreement, Concessionaire shall file with the Contract Compliance Officer for Drug Testing ("CCODT"): (a) a copy of its drug-free workplace policy, (b) the Drug Policy Compliance Agreement substantially in the form set forth in Exhibit “F”"G", together with a written designation of all safety impact positions and, (c) if applicable (e.g., e.g. no safety impact positions), the Certification of No Safety Impact Positions, substantially in the form set forth in Exhibit “G”"H". If Concessionaire files a written designation of safety impact positions with its Drug Policy Compliance Agreement, it also shall file every 6 months during the performance of this AgreementAgreement or on completion of this Agreement if performance is less than 6 months, a Drug Policy Compliance Declaration in a form substantially similar to Exhibit “H”. "I." Concessionaire shall submit the Drug Policy Compliance Declaration to the CCODT within 30 days of the expiration of each 6-month period of performance and within 30 days of completion of this Agreement. The first 6-month period begins to run on the date the City issues its Notice to Proceed or if no Notice to Proceed is issued, on the first day Concessionaire begins work under this Agreement. 10.3.3 Concessionaire also shall file updated designations of safety impact positions with the CCODT if additional safety impact positions are added to Concessionaire's employee work force. 10.3.4 Concessionaire shall require that its subcontractors comply with the Executive Order, and Concessionaire shall secure and maintain the required documents for City inspection.

DRUG DETECTION AND DETERRENCE. 12.3.1 11.4.1. It is the policy of the City to achieve a drug-free workforce and workplace. The manufacture, distribution, dispensation, possession, sale, or use of illegal drugs or alcohol by contractors while on City Premises is prohibited. Concessionaire shall comply with all the requirements and procedures set forth in the Mayor's Drug Abuse Detection and Deterrence Procedures for Contractors, Executive Order No. 1-31 ("“Executive Order"”), which is incorporated into this Agreement and is on file in the City Secretary’s Office. 12.3.2 11.4.2. Before the City signs this Agreement, Concessionaire shall file with the Contract Compliance Officer for Drug Testing ("“CCODT"”): (a) 11.4.2.1. a copy of its drug-free workplace policy, (b) 11.4.2.2. the Drug Policy Compliance Agreement substantially in the form set forth in Exhibit “F”, together with a written designation of all safety impact positions and, (c) 11.4.2.3. if applicable (e.g., no safety impact positions), the Certification of No Safety Impact Positions, substantially in the form set forth in Exhibit “G”. 11.4.3. If Concessionaire files a written designation of safety impact positions with its Drug Policy Compliance Agreement, it also shall file every 6 months during the performance of this Agreement, a Drug Policy Compliance Declaration in a form substantially similar to Exhibit “H”. Concessionaire shall submit the Drug Policy Compliance Declaration to the CCODT within 30 days of the expiration of each 6-month period of performance and within 30 days of completion of this Agreement. The first 6-month period begins to run on the date the City issues its Notice to Proceed or if no Notice to Proceed is issued, on the first day Concessionaire begins work under this Agreement.

DRUG DETECTION AND DETERRENCE. 12.3.1 (1) It is the policy of the City to achieve a drug-free workforce and workplace. The manufacture, distribution, dispensation, possession, sale, or use of illegal drugs or alcohol by contractors while on City Premises is prohibited. Concessionaire Contractor shall comply with all the requirements and procedures set forth in the Mayor's Drug Abuse Detection and Deterrence Procedures for Contractors, Executive Order No. 1-31 ("Executive Order"), which is incorporated into this Agreement and is on file in the City Secretary’s Office. 12.3.2 (2) Before the City signs this Agreement, Concessionaire Contractor shall file with the Contract Compliance Officer for Drug Testing ("CCODT"): (a) a copy of its drug-free workplace policy, (b) the Drug Policy Compliance Agreement substantially in the form set forth in Exhibit “F”, "D," together with a written designation of all safety impact positions and, (c) if applicable (e.g., e.g. no safety impact positions), the Certification of No Safety Impact Positions, substantially in the form set forth in Exhibit “G”. "E." If Concessionaire Contractor files a written designation of safety impact positions with its Drug Policy Compliance Agreement, it also shall file every 6 months during the performance of this AgreementAgreement or on completion of this Agreement if performance is less than 6 months, a Drug Policy Compliance Declaration in a form substantially similar to Exhibit “H”. Concessionaire "F." Contractor shall submit the Drug Policy Compliance Declaration to the CCODT within 30 days of the expiration of each 6-month period of performance and within 30 days of completion of this Agreement. The first 6-month period begins to run on the date the City issues its Notice to Proceed or if no Notice to Proceed is issued, on the first day Concessionaire Contractor begins work under this Agreement. (3) Contractor also shall file updated designations of safety impact positions with the CODT if additional safety impact positions are added to Contractor's employee work force. (4) Contractor shall require that its subcontractors comply with the Executive Order, and Contractor shall secure and maintain the required documents for City inspection.